Emeran A. Mayer, MD, UCLA Health
The Brain Gut Microbiome System – Implications for GI disorders
The Brain Gut Microbiome System – Implications for GI disorders
Amanda Decker (PhD candidate, Olive lab): “Bacterial Toxin Therapy for Pancreatic Ductal Adenocarcinoma” Aveline Filliol, PhD ( Schwabe Lab): “Dual functions of stellate cells in the injured liver” Ermanno Malagola, PhD (Timothy Wang Lab):“Investigating intestinal stem cell heterogeneity”
Antibiotic-resistant gut bacteria and their crosstalk in the ICU
Hepatic involvement in the MIS-C following COVID-19 infection
The Microbiota-Gut-Brain Axis
Inflammation fueling fat: Implications for lipogenesis and NAFLD
Ion transporters as regulators of the intestinal epithelial barrier
BSCAC Core Single Cell and Bioinformatics Workshop: “Single cell and advanced bioinformatics analyses in digestive organs.” All DDRCCs nationwide invited.
Understanding the connections between tissue injury, regeneration, and cancer.
Growth hormone as therapy for pediatric IBD